secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2026-05-21T10:03:12+00:00
Accession:  0001104659-26-064761
Event type: other_material
Sentiment:  positive
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus shareholders approve Scheme of Arrangement with 99.98% support
------------------------------------------------------------------------

- Court Meeting: 99.98% by value of Scheme Shares voted for the Scheme of Arrangement (24,709,337 for, 3,772 against).
- General Meeting: 99.98% of votes cast approved the Scheme Implementation Proposal (24,710,187 for, 3,922 against, 10 abstentions).
- Both meetings held May 20, 2026; total Scheme Shares entitled to vote: 40,848,893.
- All matters submitted were approved; results are final.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926064761/0001104659-26-064761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926064761/tm2615235d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-064761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer